Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | FGTI-2734 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
FGTI-2734 is a peptidomimetic inhibitor of RAS farnesylation and geranylgeranylation, which results in decreased membrane localization of RAS and downstream signaling, and potentially leads to decreased growth of RAS-mutant tumors (PMID: 31227505). |
| DrugClasses | RAS Inhibitor (Pan) 14 |
| CAS Registry Number | 1247018-19-4 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| FGTI-2734 | FGTI-2734 | 0 | 0 |
| FGTI-2734 + Sotorasib | FGTI-2734 Sotorasib | 0 | 0 |